We are live on ! Find out more
ORGO icon

Organogenesis Holdings
ORGO

0 hedge funds and large institutions have $0 invested in Organogenesis Holdings in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 27 → 0 (-27)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $281M → $0 (-$281M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 27

Holders
–
Holders Change
-27
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
27
Calls
$21.3M
Puts
–
Net Calls
+$21.3M
Net Calls Change
+$42K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$29.8M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$24.1M
3
WAM
Weiss Asset Management
Massachusetts
-$23.1M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$21.2M
5
FTCM
Fir Tree Capital Management
New York
-$17.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
1
Glazer Capital LLC
New York
– -$29.8M -2,944,040 Closed
ACH
2
ArrowMark Colorado Holdings
Colorado
– -$24.1M -2,382,176 Closed
WAM
3
Weiss Asset Management
Massachusetts
– -$23.1M -2,282,051 Closed
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
– -$21.2M -2,100,000 Closed
FTCM
5
Fir Tree Capital Management
New York
– -$17.2M -1,700,000 Closed
OAM
6
Oxford Asset Management
United Kingdom
– -$15.6M -1,538,000 Closed
GL
7
Governors Lane
New York
– -$15.4M -1,519,000 Closed
CFIC
8
City Financial Investment Company
United Kingdom
– -$14M -1,383,735 Closed
MCM
9
Moore Capital Management
New York
– -$13.1M -1,290,000 Closed
DKCM
10
Davidson Kempner Capital Management
New York
– -$13M -1,284,855 Closed
Bank of Montreal
11
Bank of Montreal
Ontario, Canada
– -$12.2M -1,200,000 Closed
BCM
12
Basso Capital Management
Connecticut
– -$11.7M -1,153,853 Closed
WRBC
13
W.R. Berkley Corp
Connecticut
– -$11.2M -1,108,178 Closed
WCMNY
14
Westchester Capital Management (New York)
New York
– -$10.7M -1,053,000 Closed
HCM
15
Highbridge Capital Management
New York
– -$10.2M -1,010,000 Closed
PAMP
16
Polar Asset Management Partners
Ontario, Canada
– -$10.1M -998,744 Closed
PC
17
Periscope Capital
Ontario, Canada
– -$6.84M -674,800 Closed
MSU
18
Mizuho Securities USA
New York
– -$6.6M -651,251 Closed
KPF
19
K2 Principal Fund
Ontario, Canada
– -$6.24M -616,020 Closed
BI
20
Bulldog Investors
New Jersey
– -$3.43M -329,683 Closed
BPIM
21
Brant Point Investment Management
New York
– -$1.91M -188,735 Closed
YCM
22
Yakira Capital Management
Connecticut
– -$1.52M -150,000 Closed
PPA
23
Parametric Portfolio Associates
Washington
– -$962K -95,000 Closed
HCMT
24
Highland Capital Management (Texas)
Texas
– -$784K -77,282 Closed
TRCT
25
Tower Research Capital (TRC)
New York
– -$26K -2,575 Closed
1
2

ORGO Hedge Fund Activity: Q4 2018 in Review

0 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q4 2018, worth a combined $0 — down 100% from $281M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of ORGO and 0 opened new positions — a net loss of 27 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Glazer Capital LLC, exiting entirely with an estimated $29.8M sold.

  • 0 institutional investors held Organogenesis Holdings (ORGO) as of Q4 2018, down from 27 in Q3 2018.
  • Funds reported $0 of Organogenesis Holdings stock for Q4 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Organogenesis Holdings positions in Q4 2018 and 27 closed out, a net change of -27 holders.
  • The largest Organogenesis Holdings seller in Q4 2018 was Glazer Capital LLC, an estimated $29.8M sold.

Based on aggregated 13F filings for Q4 2018.